Pharmacokinetics (PK) and pharmacogenetics (PG) of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis
Dymond, A., Elks, C., Martin, P., Carlile, D., Mariani, G., Lovick, S., Huang, Y., Lorch, U., Brown, H., So, K.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw368.19
Date:
October, 2016
File:
PDF, 123 KB
english, 2016